Form 4: Bausch Health Director Michael Goettler Granted 30,149 Restricted Share Units

Bausch Health Companies Inc. Director Michael Goettler was granted 30,149 restricted share units, which will vest before the 2026 Annual Meeting of Shareholders.

Summary

• Director Michael Goettler acquired 30,149 Restricted Share Units (RSUs) of Bausch Health Companies Inc.
• The transaction date for this acquisition was July 25, 2025.
• Each RSU represents a contingent right to receive one Common Share, no par value.
• The RSUs were acquired at a price of $0.
• Following this transaction, Michael Goettler directly beneficially owns 30,149 common shares (in the form of RSUs).
• The RSUs are scheduled to vest immediately before the 2026 Annual Meeting of Shareholders.

Sentiment

Score: 7

Explanation: The filing reports a standard equity grant to a director, which is generally positive for aligning interests and signaling confidence, but it does not contain significant new financial or operational information to dramatically shift sentiment.

Positives

• The grant of 30,149 Restricted Share Units to Director Michael Goettler aligns his interests with those of shareholders, as the value of the RSUs is tied to the company's future share price performance.
• Acquisition of shares by a director, even if through a grant, can signal confidence in the company's long-term prospects.

Negatives

• No explicit negatives are detailed in this Form 4 filing, which primarily reports an insider transaction.

Risks

• The value of the granted Restricted Share Units is contingent on the future performance of Bausch Health Companies Inc.'s common shares, meaning the actual value realized by the director could be lower if the share price declines.
• The RSUs are subject to a vesting period until immediately before the 2026 Annual Meeting of Shareholders, meaning the shares are not immediately available for sale.

Future Outlook

The 30,149 Restricted Share Units granted to Director Michael Goettler are scheduled to vest immediately before the 2026 Annual Meeting of Shareholders, indicating a future milestone for the realization of these equity awards.

Industry Context

This Form 4 filing reports a routine insider equity grant, which is a common practice across industries for executive and director compensation to align interests with shareholders. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• The grant of Restricted Share Units (RSUs) at a $0 acquisition price is a standard form of equity compensation for directors and executives across various industries, including pharmaceuticals and healthcare, similar to practices at companies like Pfizer, Johnson & Johnson, or Merck.
• The vesting schedule, tied to a future annual meeting, is also a common mechanism to encourage long-term commitment and performance, aligning with corporate governance best practices seen in large-cap companies.

Related Party Transactions

• The grant of Restricted Share Units to Director Michael Goettler constitutes a related party transaction, as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aims to align management interests with shareholder value creation, potentially benefiting shareholders if the company's stock price increases.
• Employees: This filing does not directly impact general employees, as it pertains to director compensation.

Next Steps

• The 30,149 Restricted Share Units are expected to vest immediately before the 2026 Annual Meeting of Shareholders.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director, which is a standard compensation practice and does not provide new material information about the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. It primarily serves to update insider ownership.

Keywords

Bausch Health Companies Inc., BHC, Form 4, SEC Filing, Insider Transaction, Restricted Share Units, RSUs, Director Compensation, Equity Grant, Michael Goettler, Share Ownership